• Number of enterprises    Total : 467

  • High-level Talents Projects

DIAChina Drug Discovery Innovation Conference held in Suzhou

time:08/24/2017 page views: resource:BioBAY

Since China Drug Information Association (DIA) established in 2015, it has held two drug discovery innovation conferences and more than 500 professionals participated. This year, the 3rd DIA China Drug Discovery Innovation Conference will hold in Suzhou BioBay, known as China’s Silicon Valley that is devoted to discovering innovative drugs. The top institutions and well-known leaders that engage in discovering new drug at home and abroad will be present in the conference.

DIA is headquartered in Washington DC, the capital of the United States, with regional offices presenting North America, Europe, Japan, China and other countries. As a neutral international organization, DIA has worked tirelessly for more than 50 years in the pharmaceutical and other health areas, providing aplatform for government, industry and academic institutions to learn and make exchanges. In short, DIA has been well and widely received.

 Elias Zerhouni, M.D.

President of Global Research & Development Sanofi and a member of the Executive Committee for Sanofi

Elias Zerhouni, M.D., is the president of Global Research &Development and a member of the Executive Committee for Sanofi.

Dr. Zerhouni’s academic career was spent at the renowned Johns Hopkins University and Hospital where he was professor of Radiology and Biomedical Engineering and senior adviser for Johns Hopkins Medicine. He served as thedirector of the Russell H. Morgan Department of Radiology and Radiological Sciences, vice dean for Research and Executive and vice dean of the School of Medicine from 1996 to 2002 before his appointment as director of the National Institutes of Health from 2002 to 2008. In that position he oversaw the NIH’s 27 institutes and centers with more than 18,000 employees and a budget of $29.5 billion (2008).

In November 2009, president Obama appointed Dr. Zerhouni as one of the first presidential U.S. science envoys.

Dr. Zerhouni has founded or co-founded five start-up companies, authored more than 200 publications and held eight patents and a number of prominent positions on several Boards, including most recently, the board of the Lasker Foundation. He is also a member of the U.S.

National Academy of Medicine and U.S. National Academy of Engineering. He also received the prestigious Legion of Honor medal from the French National Order in 2008, and was elected in 2010 as a member of the French Academy of Medicine and appointed as the chairman of Innovation at the College de France in 2011.